Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

Beloved sports presenter Mel McLaughlin is fighting for answers after she revealed she’s been battling lung cancer, the same ...

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...

SAN ANTONIO, March 10, 2026--bioAffinity Technologies launches 2,000-patient longitudinal study for its CyPath Lung noninvasive diagnostic for lung cancer.

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

Beloved sports broadcaster Mel McLaughlin has revealed she has had half of one lung removed after being diagnosed with cancer ...

Mel McLaughlin opened the Seven Network’s cricket broadcast, then disappeared. Know the news with the 7NEWS app: Download today She’d left in classic Mel style — no fuss, keeping her head down, ahead ...

"It's very traumatic. It's very triggering. It's just a lot of emotions," says Seven News presenter who reveals a diagnosis was made in December.

Beloved sports reporter Mel McLaughlin has revealed she underwent “lifesaving” cancer surgery that removed half of one lung during a prolonged absence from broadcasts and sports coverage at Seven ...

Fans and fellow commentators are sending love and support to Mel McLaughlin after the Channel 7 star revealed her battle with ...

Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a ...

In a major step towards strengthening cancer care services in the region, Government Medical College (GMC) Jammu has launched a state-of-the-art advanced molecular testing facility for cancer patients ...